Alberto A. Mendivil, MD
Alberto A. Mendivil, MD completed his undergraduate study in Animal Physiology and Neurosciences at the University of California, San Diego before receiving his medical degree at the University of Utah School of Medicine. Dr. Mendivil’s internship and residency training in Obstetrics and Gynecology was at the University of California, Irvine. His Fellowship training in Gynecologic Oncology was completed at the University of North Carolina, Chapel Hill.
Please read important information before downloading the forms
Business Address
Gynecologic Oncology Associates
351 Hospital Road, Suite 507
Newport Beach, CA 92663
Ph. 949-642-1361
Fax 949-642-1394
amendivil@gynoncology.com
________________________________________________________________________
PERSONAL:
Date of Birth: January 31, 1975
Place of Birth: Chula Vista, California, USA
Foreign language: Spanish (speak, read, and write)
________________________________________________________________________
PROFESSIONAL TRAINING:
Fellowship
Gynecologic Oncology
Department of Obstetrics and Gynecology
University of North Carolina, Chapel Hill
CB# 7572
Chapel Hill, NC 27599-7572
PH: 919-966-5996
FAX: 919-843-5387
Fellowship Program Director: John F. Boggess, MD
July 1, 2007 to June 30, 2010
Internship/ Residency
Department of Obstetrics and Gynecology
University of California, Irvine Medical Center
101 The City Drive, Bldg 56, Suite 800
Orange, CA 92868
PH: 714-456-8224
Residency Program Director: Carol A. Major, MD
June 23, 2003 to June 22, 2007
_______________________________________________________________________
BOARD CERTIFICATION:
America Board of Obstetrics and Gynecology
General Obstetrics and Gynecology, 12/2009
American Board of Obstetrics and Gynecology
Gynecologic Oncology, Passed written exam 6/25/2010
Eligible for oral exam March, 2012
________________________________________________________________________
EDUCATION:
Medical School
University of Utah School of Medicine
Date of Graduation: May 24, 2003
-Degree: M.D.
Undergraduate
University of California, San Diego
Date of Graduation: June 14, 1998
-Degree: Bachelor of Science
-Major: Animal Physiology and Neurosciences
-Minor: Health Care/ Social Issues
________________________________________________________________________
PEER REVIEWED PUBLICATIONS:
Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer. J Gynecol Oncol 2012; 23: 22-27.
Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2011, manuscript accepted for publication.
Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.
Micha JP, Mendivil A, Epstein HD, LaFlamme LA, Goldstein BH. An Unusual Case of Endometrioid Adenocarcinoma Arising from Endometriosis. 2011 J Repro Med, manuscript accepted for publication.
Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Mallory KM, Bae-Jump VL. AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. 2011 Repro Sci, manuscript accepted for publication.
Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival Outcomes for Women Undergoing Type III Robotic Radical Hysterectomy for Cervical Cancer: A 3-year experience. 2010 Gynecol Oncol, 117(2):260-5.
Cantrell LA, Zhou C, Mendivil A, Gehrig PA, Malloy KM, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy. 2009 Gyncol Oncol, 116(1): 92-98.
Boggess JF, Gehrig PA, Cantrell LA, Shafer A, Mendivil A, Rossi E, Hanna R. Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology. 2009 Obstet Gynecol, 114(3).
Mendivil A, Holloway RW, Boggess JF. Invited Review: Emergence of robotic assisted surgery in gynecologic oncology: American perspective. 2009 Gynecol Oncol, 114(2): S24-S31.
Mendivil A, Schuler KM, Gehrig PA. Invited Review: Non-Endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. 2009 Cancer Control, 16(1): 46-52.
Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? 2008 Gynecol Oncol, 111(1): 41-45.
Yessaian A, Mendivil A, Brewster WR. Population characteristics in cervical cancer trials: Search for external validity. 2005 Am J Obstet Gynecol, 192(2): 407-13.
La Cava A, Massa M, Mendivil A, Martini A, Albani S. Genetic Immunization Maps T Cell (Auto) Immune Responses to Self Antigens Homologous to Exogenous Proteins. 2002 Autoimmunity, 35(2): 105-10.
Prakken B, Wauben M, Genini D, Samodal R, Barnett J, Mendivil A, Leoni L, Albani S. Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’. 2000 Nature Medicine, 6(12): 1406-10.
BOOK CHAPTERS:
Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2011.
Mendivil A, Fowler WC. Early epithelial ovarian cancer. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010
Mendivil A, Bae-Jump VL. Germ cell tumors. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010
Mendivil A, Clarke-Pearson D. Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010
Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2009
________________________________________________________________________
ORAL PRESENTATIONS:
BRCA and the Hereditary Breast/ Ovarian Cancer Syndrome. Grand Rounds presented at Nash Regional Medical Center, Rocky Mount, NC, April 14, 2009.
Gynecologic Surgery in the Obese Patient. Grand Rounds presented at the New Hanover Regional Medical Center, Wilmington, NC, March 6, 2009.
Robotic Surgery Training in Gynecologic Oncology: A Comparison of Fellow and Attending Surgical Times. Presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 5, 2009.
A Three-Year Analysis of Endometrial Cancer Staging via Robotic Assistance. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.
A Fellow and Attending Surgeon Comparison of Robotic Surgical Outcomes in A Fellowship Training Program. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.
Metformin’s Effects on Endometrial Cancer. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.
Growth of Robotic Surgery Among Gynecologic Oncologists. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.
Management of Primary Peritoneal and Fallopian Tube Carcinomas: Are they similar to Epithelial Ovarian Cancer? 25th Annual Philip J. DiSaia Resident Paper Day. UCI Department of Obstetrics and Gynecology. Orange, CA. May 12, 2007.
Absence of Cardiotoxicity with Long-Term Use of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer. 24th Annual Philip J. DiSaia Resident Paper Day. UCI Department of Obstetrics and Gynecology. Costa Mesa, CA. May 19, 2006.
________________________________________________________________________
RESEARCH/ POSTER PRESENTATIONS:
Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, and Bae-Jump VL: Rapamycin potentiates the effects of paclitaxel in uterine papillary serous carcinoma (UPSC) cells through inhibition of cell proliferation and induction of apoptosis. Abstract presented at the Annual meeting of the American Association for Cancer Research, Washington, DC, April 2010.
O’Malley DM, Achenbach S, Skaznik-Wikiel M, Nakayama JM, Mendivil A, Havrilesky LJ, Secord AA, DeBernardo R, Gehrig PA, Fader AN: Improved survival with chemotherapy and radiation in advanced-stage uterine clear cell carcinoma. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.
O’Malley DM, Nakayma J, Secord AA, DeBernardo R, Gehrig PA, Fader AN, Mendivil A, Cohn DE, Skaznik-Wikiel M, Havrilesky L: Benefit of Adjuvant Therapy in Early Stage Clear Cell Cancer of the Uterus? Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.
Mendivil A, Vogel TJ, Gehrig PA: A survival comparison between women with uterine serous and/or clear cell carcinoma with and without a history of breast cancer. Abstract presented at the Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, May 2009.
Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual Meeting of the American Association for Cancer Research, Denver, CO, April 2009.
Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual UNC Women’s Health Research Day Conference, Chapel Hill, NC, April 2009.
Mendivil A, Cantrell LA, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Endometrial Cancer: A Three-Year Experience. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.
Cantrell LA, Mendivil A, Zhou C, Gehrig PA, Bae-Jump VL: Metformin is a potent inhibitor of endometrial cancer cell proliferation- implications for a novel treatment strategy. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.
Cantrell LA, Mendivil A, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Cervical Cancer: A Three-Year Experience. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.
Hanna R, Cantrell LA, Gehrig PA, Mendivil A, Boggess JF: A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.
Boggess JF, Shafer A, Cantrell LA, Abaid L, Mendivil A, Gehrig PA: Robotically Assisted Type III Radical Hysterectomy in a Morbidly Obese Woman. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.
Mendivil A, Hunter MI, Han E, Tewari KS: Management Of Primary Peritoneal And Fallopian Tube Carcinomas In The Platinate-Taxane Era. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.
Gehrig PA, Cantrell LA, Shafer A, Abaid L, Mendivil A, Boggess JF: What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.
Hunter MI, Ziogas A, Mendivil A, Brewster WR: Second primary breast cancer after epithelial ovarian cancer and tumors of low malignant potential. Abstract at the 39th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, CA, April 2005.
Mendivil A, Cole BC, Sawitzke A: Mapping B-cell epitopes on mycoplasma arthritidis mitogen (MAM) using lambda phage display peptide library. Abstract at the Western Student Medical Research Forum, Deer Valley, UT, February 2001.
Prakken B, Samodal R, Mendivil A, Bonnin D, Lanza P, Amox D, Roord S, DeKleer I, Jones M, Carson D, Albani S. An E. coli Heat Shock Protein dnaJ Peptide Homologous To The “Shared Epitope” Is A Trigger Of Pro-Inflammatory, TH-1 Type T Cell Responses In Patients With Early Rheumatoid Arthritis (RA). Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.
Samodal R, Louie S, Amox D, Bonnin D, Yang X, Weaver B, Mendivil A, Prakken B, Carson D, Albani S. Immunomodulatory Effects Of Treatment With A “Shared Epitope” Peptide In Patients With Rheumatoid Arthritis. Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.
________________________________________________________________________
LEADERSHIP:
Administrative Chief Resident, UCI Medical Center, Dept. of OB/GYN, 2006-2007
ACOG Junior Fellow District IX, Section 7 Chair, 2005-2006
‘Life of Medicine’ undergraduate course co-instructor, UC Irvine, 2005
Student Body Co-President, University of Utah School of Medicine, 2002-2003
Student Advisory Committee, Department of Obstetrics and Gynecology, University of Utah School of Medicine, 2001
Association of Minority Medical Students, University of Utah School of Medicine Co-President, 1999-2000
National Medical Fellowships, Academy Fellow, University of Utah School of Medicine Representative, 2001-2002
2nd Year Class Co-President, University of Utah School of Medicine, 2000-2001
Executive Committee member, University of Utah School of Medicine, 2000-2001, 2002-2003
Alumni Association Board Member, University of Utah School of Medicine, 2000-2001, 2002-2003
Community Outreach Program Student Coordinator, University of Utah School of Medicine, 2000-2001
International Pharmacy Student Foundation Book Appeal Project, 2000
-Book drive organizing committee chairman (medical school section)
-Over 600 medical books were collected and donated to Cruz Roja Mexicana Hospital, Tijuana, Mexico
Medical Spanish Instructor- University of Utah School of Medicine, 1999-2001
________________________________________________________________________
AWARDS:
Best Fellow Presentation, Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, September, 2008
Philip J. DiSaia, MD UCI Medical Student Teaching Award, June 2007
UCI School of Medicine Resident Teaching Award, June 2007
UCI School of Medicine Resident Teaching Award, June 2005
UCI Dept. of OB/Gyn 2ND Year Resident Teaching Award, June 2005
UCI Dept. of OB/Gyn Teaching Resident of the Month, July 2004
UCI Dept. of Internal Medicine Outpatient Clinic Resident of the Month, July 2003
University of Utah School of Medicine Alumni Association Student Award, 2003
Bristol-Myers Squibb/ NMF Academic Medicine Research Fellowship, 2002
Linda Derrick Wood Scholarship, 2002
The Endocrine Society Research Fellowship, 2002
Herbert W. Nickens, M.D. Minority Medical Student Scholarship, 2001
National Medical Fellowships, Inc. Scholarship, 2001
Western Student Medical Research Award, 2001
Robert Wood Johnson Foundation Award, 2000-2001
Edward C. Klatt, M.D. Scholarship, 2000-2001
Bristol-Myers Squibb/ NMF Academic Medicine Fellowship (Finalist), 2000
Summer Institute for Medical Students, Betty Ford Center, Scholarship, 2000
National Medical Fellowships, Inc. Scholarship, 2000
Medical Student Research Fellowship, U of Utah School of Medicine, 2000
Dean A. Moffat, M.D. Memorial Scholarship, 1999-2000
Bernett Love Memorial Scholarship, 1999-2000
Undergraduate Research Scholar, University of California, San Diego, 1997
Howard Hughes Research Stipend, University of California, San Diego, 1997
Academic Grant, University of California, San Diego, 1993-1994
David Holmgren Memorial Scholarship, 1993
________________________________________________________________________
PROFESSIONAL ASSOCIATIONS:
Orange County California Medical Association, 2003-2007
Mid-Atlantic Gynecologic Oncology Society, 2008-present
Society of Gynecologic Oncologists, Fellow-in-training, 2007-present
American College of Surgeons, Resident-in-training, 2008-present
American College of Obstetricians and Gynecologists, Junior Fellow, 2004-present
National Hispanic Medical Association, 2000-2003